132 related articles for article (PubMed ID: 32486995)
1. [Opioid therapy in patients with liver cirrhosis].
Krähenbühl S
Ther Umsch; 2020; 77(1):14-19. PubMed ID: 32486995
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. [Opioids in patients with renal impairment].
Pfefferkorn F; Harings-Kaim A; Schönenberger M; Leuppi-Taegtmeyer A
Ther Umsch; 2020; 77(1):10-13. PubMed ID: 32486992
[TBL] [Abstract][Full Text] [Related]
4. [Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Vieira C; Brás M; Fragoso M
Acta Med Port; 2019 May; 32(5):388-399. PubMed ID: 31166900
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.
Wen RY; Atayee RS; Edmonds KP
J Palliat Med; 2022 Nov; 25(11):1686-1691. PubMed ID: 35559657
[No Abstract] [Full Text] [Related]
6. Sublingual absorption of selected opioid analgesics.
Weinberg DS; Inturrisi CE; Reidenberg B; Moulin DE; Nip TJ; Wallenstein S; Houde RW; Foley KM
Clin Pharmacol Ther; 1988 Sep; 44(3):335-42. PubMed ID: 2458208
[TBL] [Abstract][Full Text] [Related]
7. Opioid-induced constipation in chronic pain: Experience with 180 patients.
Velázquez Rivera I; Velázquez Clavarana L; García Velasco P; Melero Ramos C
J Opioid Manag; 2019; 15(1):69-76. PubMed ID: 30855724
[TBL] [Abstract][Full Text] [Related]
8. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
9. Opioids for pain.
Med Lett Drugs Ther; 2022 Dec; 64(1665):193-200. PubMed ID: 36541938
[No Abstract] [Full Text] [Related]
10. [New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone].
Takagi Y; Aruga E
Gan To Kagaku Ryoho; 2018 Feb; 45(2):205-211. PubMed ID: 29483406
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
Atluri S; Sudarshan G; Manchikanti L
Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats.
Pypendop BH; Ilkiw JE; Shilo-Benjamini Y
J Vet Pharmacol Ther; 2014 Jun; 37(3):295-300. PubMed ID: 24236993
[TBL] [Abstract][Full Text] [Related]
13. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
Feng XQ; Zhu LL; Zhou Q
J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
[TBL] [Abstract][Full Text] [Related]
14. Opioid pharmacokinetic drug-drug interactions.
Overholser BR; Foster DR
Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
16. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
17. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
[TBL] [Abstract][Full Text] [Related]
18. [Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
[TBL] [Abstract][Full Text] [Related]
19. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects.
Baldo BA
Arch Toxicol; 2018 Aug; 92(8):2457-2473. PubMed ID: 29916050
[TBL] [Abstract][Full Text] [Related]
20. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
